Physician profile
Ron Lichtenstein
NPI 1447243191
$3,261.74
in general payments reported to CMS, 2019-2025
26 companies · $716 in 2025
The $716 reported for 2025 was more than what 81% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $229 · 2021: $334 · 2022: $416 · 2023: $636 · 2024: $653 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,906 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,905.62 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $340.10 | 2019-2023 | |
| Daiichi Sankyo INC. | $326.77 | 2019-2023 | Injectafer |
| Coopersurgical, INC. | $267.71 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Astellas Pharma US INC | $259.77 | 2023-2025 | Veozah |
| Shield Therapeutics INC | $254.71 | 2023-2025 | Accrufer |
| Organon LLC | $244.03 | 2021-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $203.24 | 2023-2025 | Myfembree |
| Evofem Biosciences, INC. | $184.71 | 2022-2025 | Phexxi, Solosec, Phexx |
| Hologic Sales and Service, LLC | $177.68 | 2019-2025 | Aptima, Acessa Provu System, Novasure |
| Mayne Pharma Commercial LLC | $145.54 | 2023-2025 | |
| Therapeuticsmd, INC. | $143.11 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $135.84 | 2019-2021 | |
| Optumhealth Care Solutions, LLC | $121.91 | 2023-2025 | Vivify Health Care Team Portal 001, Eitan Medical, Vivify Health Care Team Portal |
| Bayer Healthcare Pharmaceuticals INC. | $59.64 | 2019-2023 | |
| Smith+Nephew, INC. | $57.48 | 2019-2025 | Pico 14 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dysis Medical, INC. | $52.58 | 2020 | |
| Exeltis, USA INC. | $52.13 | 2024-2025 | Slynd |
| Myovant Sciences INC. | $51.69 | 2021-2022 | |
| Agile Therapeutics, INC. | $35.13 | 2023 | Twirla |
| Pfizer INC. | $34.11 | 2023 | |
| Convatec INC. | $31.23 | 2025 | |
| Amag Pharmaceuticals, INC. | $19.02 | 2019 | |
| Davol INC. | $17.02 | 2024 | Arista Ah Flexitip |
| Sage Therapeutics, LLC | $16.79 | 2025 | Zurzuvae |
| Ethicon US, LLC | $16.01 | 2025 | Surgicel Nu-Knit, Surgiflo Hemostatic Matrix, Stratafix |
| Ferring Pharmaceuticals INC. | $13.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ron Lichtenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.